FIVE's strong Q4 comps, fueled by rising traffic, higher spending and broad demand, point to durable growth momentum heading into fiscal 2026.
NESR, LCUT and FIVE made it to the Zacks Rank #1 (Strong Buy) growth stocks list on March 31st, 2026.
Here is how Five Below (FIVE) and Herbalife Ltd (HLF) have performed compared to their sector so far this year.
HTHT, FIVE, and SANM it to the Zacks Rank #1 (Strong Buy) growth stocks list on March 27, 2026.
Jim Cramer made a bold call on Five Below this week, and the numbers behind it are hard to argue with.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
FIVE, HTHT and TTEC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on March 24, 2026.
Five Below (FIVE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Five Below (FIVE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Five Below delivered stronger-than-expected FY2025 results, outperforming its own guidance with $4.76B revenue and 15.4% Q4 comps. FIVE's effective social media marketing and higher-priced merchandise drove traffic and sales, but 2026 faces tougher comps and limited further price hikes. Management's 2026 guidance appears conservative; I estimate 15% revenue growth to $5.74B, above the company's $5.25B midpoint target.
Five Below, Inc. delivered a standout Q4, with 24.3% revenue growth and 15.4% comp sales, outperforming peers and market expectations. Management's strategy of trend-right, extreme value merchandise is driving robust top-line growth and positioning FIVE to benefit from shifting consumer behavior. Guidance for FY2025–2026 exceeds consensus, with projected $5.25B revenue and $7.74–$8.25 adj. EPS, supporting a buy rating but with valuation caution.